Owain Bennallack and his fellow Fools Nathan Parmelee and Nate Weisshaar explore the mega-merger mania that has gripped the pharmaceutical sector. Do these big deals make sense for shareholders, and what should you be doing? They also bash bankers’ outrageous bonuses and weigh up the pros and cons of AIM shares, before concluding as usual with three shares worth watching.
Are you looking to profit from this uncertain economy? “10 Steps To Making A Million In The Market“ is the Motley Fool’s FREE guide to help Britain invest — better. We urge you to read the report today while it remains available. Just click here now!